Patents/Assignees

Modalis Therapeutics Corporation

3 patents in portfolio

US12502418utility2025
Method for Treating Muscular Dystrophy by Targeting LAMA1 Gene
0 cites
US12152259utility2024
Modified CAS9 Protein, and Use Thereof
0 cites
US11591621utility2023
Method of Treating Diseases Associated with Elevated KRAS Expression Using CRISPR-GNDM System
0 cites